BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Piwowarczyk L, Stawny M, Mlynarczyk DT, Muszalska-Kolos I, Goslinski T, Jelińska A. Role of Curcumin and (-)-Epigallocatechin-3-O-Gallate in Bladder Cancer Treatment: A Review. Cancers (Basel) 2020;12:E1801. [PMID: 32635637 DOI: 10.3390/cancers12071801] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Han Y, Zhou M, Mcclements DJ, Liu F, Cheng C, Xiong J, Zhu M, Chen S. Investigation of a novel smart and active packaging materials: Nanoparticle-filled carrageenan-based composite films. Carbohydrate Polymers 2022. [DOI: 10.1016/j.carbpol.2022.120331] [Reference Citation Analysis]
2 Hashemi M, Mirzaei S, Barati M, Hejazi ES, Kakavand A, Entezari M, Salimimoghadam S, Kalbasi A, Rashidi M, Taheriazam A, Sethi G. Curcumin in the treatment of urological cancers: Therapeutic targets, challenges and prospects. Life Sci 2022;309:120984. [PMID: 36150461 DOI: 10.1016/j.lfs.2022.120984] [Reference Citation Analysis]
3 Piwowarczyk L, Stawny M, Piwowarczyk K, Mlynarczyk DT, Muszalska-Kolos I, Wierzbicka M, Goslinski T, Jelinska A. Role of curcumin in selected head and neck lesions. Limitations on the use of the Hep-2 cell line: A critical review. Biomed Pharmacother 2022;154:113560. [PMID: 36030583 DOI: 10.1016/j.biopha.2022.113560] [Reference Citation Analysis]
4 Wang S, Zeng T, Zhao S, Zhu Y, Feng C, Zhan J, Li S, Ho C, Gosslau A. Multifunctional health-promoting effects of oolong tea and its products. Food Science and Human Wellness 2022;11:512-23. [DOI: 10.1016/j.fshw.2021.12.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
5 Li Z, Feng C, Dong H, Jin W, Zhang W, Zhan J, Wang S. Health promoting activities and corresponding mechanism of (–)-epicatechin-3-gallate. Food Science and Human Wellness 2022;11:568-78. [DOI: 10.1016/j.fshw.2021.12.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Piwowarczyk L, Kucinska M, Tomczak S, Mlynarczyk DT, Piskorz J, Goslinski T, Murias M, Jelinska A. Liposomal Nanoformulation as a Carrier for Curcumin and pEGCG—Study on Stability and Anticancer Potential. Nanomaterials 2022;12:1274. [DOI: 10.3390/nano12081274] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Chen Y, Du F, Tang L, Xu J, Zhao Y, Wu X, Li M, Shen J, Wen Q, Cho CH, Xiao Z. Carboranes as unique pharmacophores in antitumor medicinal chemistry. Mol Ther Oncolytics 2022;24:400-16. [PMID: 35141397 DOI: 10.1016/j.omto.2022.01.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
8 Kejík Z, Kaplánek R, Dytrych P, Masařík M, Veselá K, Abramenko N, Hoskovec D, Vašáková M, Králová J, Martásek P, Jakubek M. Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design. Pharmaceutics 2021;13:1879. [PMID: 34834295 DOI: 10.3390/pharmaceutics13111879] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
9 Jöhrer K, Ҫiҫek SS. Multiple Myeloma Inhibitory Activity of Plant Natural Products. Cancers (Basel) 2021;13:2678. [PMID: 34072312 DOI: 10.3390/cancers13112678] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Mehan S, Rahi S, Upadhayay S, Khan A. Polyphenols Targeting and Influencing Cellular Signaling During Progression and Treatment of Cancer. Polyphenols-based Nanotherapeutics for Cancer Management 2021. [DOI: 10.1007/978-981-16-4935-6_4] [Reference Citation Analysis]
11 Miyata Y, Matsuo T, Ohba K, Mitsunari K, Mukae Y, Otsubo A, Harada J, Matsuda T, Kondo T, Sakai H. Present Status, Limitations and Future Directions of Treatment Strategies Using Fucoidan-Based Therapies in Bladder Cancer. Cancers (Basel) 2020;12:E3776. [PMID: 33333858 DOI: 10.3390/cancers12123776] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
12 Ashrafizadeh M, Zarrabi A, Hushmandi K, Hashemi F, Rahmani Moghadam E, Raei M, Kalantari M, Tavakol S, Mohammadinejad R, Najafi M, Tay FR, Makvandi P. Progress in Natural Compounds/siRNA Co-delivery Employing Nanovehicles for Cancer Therapy. ACS Comb Sci 2020;22:669-700. [PMID: 33095554 DOI: 10.1021/acscombsci.0c00099] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 19.5] [Reference Citation Analysis]